pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
NEUROCRINE BIOSCIENCES INC ($NBIX) · news · pharmadog
← back to NEUROCRINE BIOSCIENCES INC
News mentioning $NBIX
40
stories
Aug 12, 26
STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial
stat
Aug 12, 26
STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies
stat
Aug 12, 26
STAT+: Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health care
stat
Aug 12, 26
STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say
stat
Aug 10, 26
As BMS’ Cobenfy struggles to gain traction, MapLight knocks on the door
biospace
Aug 3, 26
Novo’s late-stage IL-6 stumble shakes inflammation space
biospace
Jul 31, 26
Novo setback casts doubt on a new way to treat heart disease
biopharma dive
Jul 23, 26
Chutes & Ladders—Biogen R&D vet gets in Formation
fiercebiotech
Jul 7, 26
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
biopharma dive
May 15, 26
FDA hold puts Aardvark Prader-Willi drug in limbo
biopharma dive
← prev
page 2 of 2
next →